Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, octobre 27
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Tandem Diabetes Care Inc
TNDM
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$18.90
1.47
8.43%
Dern. MÀJ: Oct 26, 7:42 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Résultats:
Résultats Q3 2026 dans dans 10 jours à partir de maintenant le jeu. nov. 5th, après la fermeture du marché
Tandem Diabetes Care Financials
Tandem Diabetes Care (TNDM) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Tandem Diabetes Care Q2 EPS $(0.31) Beats $(0.32) Estimate, Sales $254.560M Miss $254.978M Estimate
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.32) by 3.13 percent. This is a 60.26 percent increase over losses of $(0.78) per share
Benzinga Newsdesk
PRO
Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.074B Est
Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion to $1.065 billion-$1.085 billion vs $1.074 billion estimate.
Benzinga Newsdesk
PRO
Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.076B Est.
Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion to $1.065 billion-$1.085 billion vs $1.076 billion estimate.
Benzinga Newsdesk
PRO
Tandem Diabetes Care Q1 Adj. EPS $(0.30) Beats $(0.45) Estimate, Sales $247.221M Beat $241.125M Estimate.
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.45) by 33.33 percent. This is a 54.55 percent increase over losses of $(0.67) per share
Benzinga Newsdesk
Dow Jumps Over 200 Points After Court's Tariff Ruling: Investor Sentiment Improves, Greed Index Remains In 'Fear' Zone
U.S. stocks rise after Supreme Court decision on tariffs. Fear & Greed index eases but remains in 'Fear' zone.
Avi Kapoor
Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook
Tandem Diabetes stock surges after earnings beat and margin growth, as investors weigh 2026 sales guidance and market momentum.
Vandana Singh
